Skip to main content
Log in

A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

In patients with cardiovascular disease, a high pulse pressure is related to an increased risk of cardiovascular events but in patients with advanced heart failure, a low pulse pressure is predictive of adverse (cardiovascular) events.

Aim

We studied the prognostic importance of pulse pressure in a group of post-myocardial infarction patients, with and without signs and symptoms of heart failure. Subjects had been randomised in the CAPRICORN clinical trial, and followed up for a mean of 1.3 years.

Methods

Blood pressure was measured in 1,955 patients with a left ventricular ejection fraction ≤40%, between 3 and 21 days post myocardial infarction. Cox proportional survival models were reproduced for those with Killip Class I (n = 1342) versus classes II/III/IV heart failure (n = 613).

Results

Overall mean (SD) age was 63 (12) years, mean (SD) left ventricular ejection fraction 33(6)%, mean (SD) baseline blood pressure was 121 (17)/74 (10) mmHg and most (73%) were male. In patients with Killip Class 1, pulse pressure was not predictive for any outcome. However, in patients with Killip Class II–IV, a low pulse pressure independently predicted all cause mortality (HR 0.83 per 10 mmHg, CI 0.71–0.98, p = 0.025), cardiovascular mortality (HR 0.83 per 10 mmHg, CI 0.70–0.98, p = 0.025) and sudden death (HR 0.77 per 10 mmHg, CI 0.60–1.00, p = 0.047). A lower pulse pressure did not predict hospitalisation for worsening heart failure.

Conclusion

A low pulse pressure is an independent predictor of mortality in subjects with depressed left ventricular ejection fraction after a recent myocardial infarction and evidence of Killip Class II–IV heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Voors AA, Petrie CJ, Petrie MC, Charlesworth A, Hillege HL, Zijlstra F, McMurray JJ, van Veldhuisen DJ (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759–1764

    Article  PubMed  CAS  Google Scholar 

  2. Petrie CJ, Voors A, van Veldhuisen DJ (2009) Low pulse pressure is an independent predictor of mortality in non ischemic, but not in ischemic advanced heart failure patients. Int J Cardiol 131:336–344

    Article  PubMed  Google Scholar 

  3. Schillaci G, Di Luzio S, Coluccini M, Gonzini L, Porcu M, Pozzar F, Maggioni AP, Italian Network of Congestive Heart Failure Registry (2004) A low pulse pressure is an independent predictor of mortality in heart failure: data from a large nationwide cardiology database (IN-CHF Registry). Ital Heart J 5:892–898

    PubMed  Google Scholar 

  4. Yildiran T, Koc M, Bozkurt A, Sahin DY, Unal I, Acarturk E (2010) Low pulse pressure as a predictor of death in patients with mild to advanced heart failure. Tex Heart Inst J 37(3):284–290

    PubMed  Google Scholar 

  5. Aronson D, Burger AJ (2004) Relation between pulse pressure and survival in patients with decompensated heart failure. Am J Cardiol 93:785–788

    Article  PubMed  Google Scholar 

  6. Mitchell GF, Moye LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA (1997) Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. Circulation 96:4254–4260

    PubMed  CAS  Google Scholar 

  7. CAPRICORN Investigators (2001) Effect of carvedilol on outome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 57:138–190

    Google Scholar 

  8. Dargie HJ, The CAPRICPORN Steering Committee (2000) Design and methodology of the CAPRICORN trial—a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Fail 2(3):325–332

    Article  PubMed  CAS  Google Scholar 

  9. Dart AM, Kingwell BA (2001) Pulse pressure. A review of mechanisms and clinical relevance. J Am Coll Cardiol 37(4):975–984

    Article  PubMed  CAS  Google Scholar 

  10. Fosbøl EL, Seibaek M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia ON Dofetilide Study Group (2010) Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study. Int J Cardiol 140(3):279–286

    Article  PubMed  Google Scholar 

  11. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA, Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24):3738–3744

    Article  PubMed  Google Scholar 

  12. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA, Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352(25):2581–2588

    Article  PubMed  CAS  Google Scholar 

  13. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285–1295

    Article  PubMed  CAS  Google Scholar 

  14. European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM), Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines (CPG) (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10(10):933–989

    Google Scholar 

  15. Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Colin J. Petrie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petrie, C.J., Voors, A.A., Robertson, M. et al. A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study. Clin Res Cardiol 101, 29–35 (2012). https://doi.org/10.1007/s00392-011-0360-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-011-0360-x

Keywords

Navigation